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Biosynthesis of Deoxyamphotericins and
Deoxyamphoteronolides by Engineered
Strains of Streptomyces nodosus
and neurotoxicity, due to low water solubility and inter-
actions with cholesterol in mammalian cell membranes
[3]. As the incidence of life-threatening fungal infections
is increasing [4], there is an urgent need to develop
effective new polyene-based antibiotics with reduced
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Numerous amphotericin analogs have been made byUniversity College Dublin
Dublin 4 chemical modification of the carboxyl and amino groups
[5, 6]. Some of these analogs show improved antifungalIreland
2 Department of Chemistry specificity, particularly amphotericin B methyl ester.
This indicates that more extensive structural alterationsUniversity of Leicester
University Road could further improve the therapeutic index. However,
it has proved difficult to chemically modify the macrolac-Leicester LE1 7RH
United Kingdom tone ring. An ability to understand and manipulate the
biosynthetic pathway would enable production of large
numbers of new analogs with alterations on the macro-
lactone and the sugar, any of which may prove to be aSummary
clinically important alternative to the toxic amphoter-
icin B.Amphotericin B is an antifungal antibiotic produced
The biosynthesis of the amphotericins has been inves-by Streptomyces nodosus. During biosynthesis of am-
tigated by feeding experiments with 13C-labeled precur-photericin, the macrolactone core undergoes three
sors [7] and the biosynthetic gene cluster has been char-modifications: oxidation of a methyl branch to a car-
acterized [8]. A sluggish enoyl reductase (ER5) is believedboxyl group, mycosaminylation, and hydroxylation.
responsible for the coformation of amphotericins A andGene disruption was undertaken to block two of these
B (1b, 1a). The macrolactone core (1i, 1j) is assembledmodifications. Initial experiments targeted the amph-
from acetate and propionate units by a large modularDIII gene, which encodes a GDP-D-mannose 4,6-dehy-
polyketide synthase encoded within the gene cluster,dratase involved in biosynthesis of mycosamine. Anal-
as are enzymes that assemble the mycosamine sugarysis of products by mass spectrometry and NMR
from GDP-D-mannose, and the glycosyl transferase toindicated that the amphDIII mutant produced 8-deoxy-
attach the sugar to the ring. The cluster also containsamphoteronolides A and B. This suggests that gly-
genes for two cytochrome P450 monooxygenases thatcosylation with mycosamine normally precedes C-8
are thought responsible for hydroxylation at C-8 andhydroxylation and that formation of the exocyclic car-
oxidation of the C-16 methyl branch to a carboxyl group.boxyl group can occur prior to both these modifica-
Techniques have been developed for replacement of S.tions. Inactivation of the amphL cytochrome P450
nodosus genes to allow the engineered biosynthesis ofgene led to production of novel polyenes with masses
amphotericin analogs [8]. Here, these developments areappropriate for 8-deoxyamphotericins A and B. These
exploited to disrupt genes involved in the late steps ofcompounds retained antifungal activity and may be
amphotericin biosynthesis. The results provide the firstuseful new antibiotics.
insights into the order in which these tailoring modifica-
tions occur and also generate previously unavailable
Introduction analogs of amphotericins for therapeutic testing.
The heptaene macrolide amphotericin B (1a) (Figure 1)
is a medically important antifungal agent that is pro- Results
duced by Streptomyces nodosus in combination with
the tetraene amphotericin A (1b). The antifungal activity Disruption of the amphDIII Gene
of polyenes results from specific interactions with ergo- A 2091 base pair region of the amphotericin cluster
sterol, the predominant sterol lipid in fungal membranes. (nucleotides 3474–5565; [8]) containing the amphDIII
Polyene-sterol complexes associate to form transmem- gene was amplified by PCR with oligonucleotides de-
brane channels that allow unregulated loss of ions and signed to introduce unique BamHI and PstI sites at op-
small molecules causing cell death [1]. Amphotericin B posite ends of the product. These sites were used to
has very high activity and is the most effective drug for clone the amplified DNA into pUC118. The resulting plas-
the treatment of life-threatening systemic fungal infec- mid was digested with BglII, which cuts a single site
tions [2], and resistance still has not emerged as a seri- approximately in the center of the amphDIII gene. The
ous problem even after more than 40 years of regular cohesive ends were repaired with T4 DNA polymerase
clinical use. However, amphotericin B does have severe and ligated to create a frameshift mutation. The removal
side effects that include nephrotoxicity, cardiotoxicity, of the BglII site was verified by restriction analysis. The
BamHI-PstI fragment was cloned into KC515 and re-
combinant phage were identified by PCR with primers*Correspondence: patrick.caffrey@ucd.ie
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Figure 1. Structure of Amphotericin B and Analogs
specific for the insert. The KC515-amphDIII phage was of the amphDIII region PCR products amplified from
S. nodosus ATCC14899 and one of the replacementpropagated on S. nodosus, and three thiostrepton-resis-
tant lysogens were isolated and purified. One of the mutants.
lysogens was cultured in the absence of thiostrepton to
allow prophage excision and gene replacement to oc- Analysis of Polyenes Made
by the amphDIII Mutantcur. The mycelial cells were converted to protoplasts to
generate single cell units. After protoplast regeneration, The amphDIII mutant was grown on fructose-dextrin-
soybean medium [7] and was shown by UV spectropho-single colonies were tested for thiostrepton sensitivity
to identify clones in which a second crossover event had tometry to produce tetraenes (50–250 mg/L culture
broth) and lower levels of heptaenes, predominantly inexcised the prophage. Nineteen thiostrepton-sensitive
revertants were obtained from 208 clones. Genomic the sedimentable mycelial fraction of the cultures. This
mycelial sediment was extracted with methanol, and theDNA was isolated from these revertants, and the amph-
DIII region was amplified by PCR and subjected to re- tetraenes were partially purified by selective precipita-
tion (removing some heptaene and more polar polyenestriction analysis. Two of the revertants gave PCR prod-
ucts that lacked a BglII site and were identified as products). Analysis by ESMS indicated that the major
products present were 8-deoxyamphoteronolides alongamphDIII mutants. Figure 2 shows restriction analysis
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Figure 2. Targeted Inactivation of the amphDIII Gene
(A) A double crossover recombination event results in replacement of the amphDIII gene with a form containing a frameshift mutation and
lacking a BglII site. K and Bg denote the unique KpnI and BglII sites within the 1035 base pair amphDIII gene. The star denotes the frameshift
mutation. The small arrows represent the primers used to amplify the amphDIII region.
(B) Analysis of a typical replacement mutant. The oligonucleotide primers described in the text were used to amplify the amphDIII region from
S. nodosus ATCC14899 and from the amphDIII mutant. The 2091 bp PCR products were treated with BglII or KpnI. The region amplified from
wild-type S. nodosus was cut by BglII to give the expected 973 and 1118 bp fragments (lane 1), whereas the product amplified from the
mutant was resistant to cleavage by BglII (lane 3). The DNA amplified from both strains gave the expected 446 and 1645 bp fragments when
digested with KpnI (lanes 2 and 4).
with some amphoteronolides. Figure 3 shows spectra thioester intermediate (2c) and to carry out stereospe-
cific antireduction to form the (2S,3S )-3-hydroxy-2-obtained with a sample enriched in 8-deoxyamphotero-
nolide A (1f) with some amphoteronolide A. methylbutanoyl thioester intermediate (2e) (Figure 5).
37-epi-8-deoxyamphoteronolides would result from KR1The partially purified 8-deoxyamphoteronolides were
converted to methyl esters (1g and 1h) and a fraction generating the opposite alcohol stereochemistry to form
2f. 36-epi-8-deoxyamphoteronolides would arise fromcontaining mainly tetraene products further purified by
normal phase HPLC, from which two tetraenes were the selection by KR1 of the unepimerized substrate (2b),
with ketoreduction to form 2d (Figure 5). The data doisolated, both with the expected molecular weight
(778.4). Analysis of one of these components by proton, not exclude the possibility that antireduction still occurs,
but on the unepimerized substrate, to give the bis-epi-carbon, and proton-proton 2D NMR gave spectra con-
sistent with methyl 8-deoxyamphoteronolide A (1h) (Fig- mer (2R, 3R )-3-hydroxy-2-methylbutanoyl thioester.
The literature to date is consistent with all of these possi-ure 4A) [9]. Preliminary NMR analysis of the second
component gave spectra consistent with either methyl ble mechanisms. Complete structural characterization
of the products should help to resolve the issue.37-epi-8-deoxyamphoteronolide B or methyl 36-epi-8-
deoxyamphoteronolide B (Figure 4B). This assignment epi-Amphoteronolides have not been reported, and
their formation suggests that although the remainingis based upon a large upfield shift of H-37 in the proton
and 2D NMR spectra from 5.2 in 1h (coupled to methyl extension modules can tolerate an “incorrect” epi-dike-
tide and extend it to form the epimerized macrolactonedoublet at 1.2 ppm) to 4.0 ppm (coupled to methyl dou-
blet at 1.2 ppm) in the epimer. These compounds are and that the AmphN cytochrome P450 efficiently oxi-
dizes the C-41 methyl to a carboxyl group (vide infra), theundergoing further characterization (B.R., unpublished
data). Molecular modelling indicates that epimerization mycosaminyltransferase does not efficiently recognize
the epi-8-deoxyamphoteronolide as substrate. S. nodo-at either C-36 or C-37 results in a major change in macro-
lactone conformation. The stereochemistry at these sus ATCC14899 was subsequently found to produce a
minor polyene with chromatographic properties identi-centers is determined by module 1 of the amphotericin
PKS. Literature evidence suggests that this module uses cal to those of the putative epi-8-deoxyamphoteronolide
(B.R., unpublished data). This indicates that these com-a (2S )-methylmalonyl extender unit (2a) and upon con-
densation with acetyl CoA initially generates a (2R )-2- pounds are normally generated at low levels by the am-
photericin PKS but were only detected during character-methyl-3-oxoacyl chain (2b) [10, 11] that can readily
epimerize at C-2. Based on the stereochemistry ob- ization of 8-deoxyamphoteronolides formed by the
amphDIII mutant. This is the first known example of aserved in amphotericin B, the Amph KR1 appears to
select the 2-epimerized (2S )-2-methyl-3-oxobutanoyl natural (nonchimaeric) polyketide synthase in which a
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Figure 3. Analysis of Polyenes Produced by amphDIII Mutant by Mass Spectrometry
Typical extracts were found to contain 8-deoxyamphoteronolide A (1f) when analyzed by ESMS in positive ion mode (A) and negative ion
mode (B). A sodium adduct was detected in positive ion mode. A lesser amount of amphoteronolide A (M  Na  803) was detected by
positive ion ESMS only. Detection in this mode could be more sensitive for the 8-hydroxylated amphoteronolides if Na coordinates to the
1,2 diol present in these compounds.
lapse in programming fidelity results in production of NDP-deoxysugar flexibility in macrolide glycosyltrans-
ferases has been documented. An oleandrosyltrans-epimeric macrolactones.
Polyenes were also detected in culture supernatants ferase OleG2 that normally utilizes dTDP-L-oleandrose
when introduced into Saccharopolyspora erythraeaof amphDIII strains, and more polar polyene fractions
were obtained when mycelial extracts were chromato- EryBV mutant (lacking dTDP-L-oleandrose) was shown
able to complement the missing EryBV mycarosyltrans-graphed. These polyenes may represent analogs of am-
photericin that are modified with alternative sugars. The ferase activity, but by attaching rhamnose to form 3-L-
rhamnosyl-6-deoxyerythromycin B [12, 13]. The dTDP-absence of the “normal” glycosylation (which would
allow rapid export from the cell), resulting in a slow build L-rhamnose is believed to be present in the cytoplasm
as a cell wall building block.up of polyenes in the cell, may allow other relatively
slow conversions to now occur to the macrolactone. In As 8-deoxyamphoteronolides may exist in amphDIII
mutant cells for several days, other adventitious glyco-the absence of GDP-mycosamine, the AmphDI myco-
saminyl glycosyl transferase might be capable of using sylation processes may very slowly occur during this
time, resulting in the glycosylation of other hydroxylGDP-D-mannose, dTDP-D-glucose, or even dTDP-L-
rhamnose as substrate to convert a fraction of the agly- groups. The polyenes nystatin A3 and candidoin each
have an additional dideoxyhexose sugar residue attachedcone to polar glycosylated minor products, with manno-
syl, glucosyl, or rhamnosyl residues attached at C-19. at the position corresponding to C-35 of amphotericin [14].
The polyenes produced by the amphDIII mutant wereIndeed, a minor compound with a mass appropriate
for hexosyl-amphoteronolide A (M  H  941.5) was tested for antifungal activity in agar diffusion assays with
Saccharomyces cerevisiae as an indicator organism. Noroutinely detected in extracts from the amphDIII mutant
(Figure 3B). To investigate this compound further, a po- inhibition zones were detected when extracts containing
14 g total tetraene and 6 g total heptaene per ml werelar tetraene fraction was methylated and purified further.
Analysis by positive ion ESMS showed a large peak at assayed (data not shown). The amphoteronolides and
their hexosyl analogs had dramatically reduced activity979.4, corresponding to the sodium adduct of desmy-
cosaminyl O-mannosylamphotericin A methyl ester, or compared to amphotericins A and B extracted from wild-
type S. nodosus. This observation is consistent withthe O-glucosyl isomer, with no evidence of the 8-deoxy
analogs (data not shown). Presumably, the AmphL cyto- previous findings that a positive charge on the amino
group of mycosamine is essential for significant antifun-chrome P450 recognizes the corresponding hexosyl
8-deoxy intermediate and hydroxylates it. gal activity [5].
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Figure 4. NMR Analysis of Polyenes Pro-
duced by the amphDIII Mutant
(A) Proton NMR (400 MHz) spectrum of methyl
8-deoxyamphoteronolide A (1g) showing the
C-37 proton at 5.2 ppm () and the coupled
doublet at 1.2 ppm (*).
(B) Proton NMR spectrum of methyl epi-8-
deoxyamphoteronolide A showing the C-37
proton at 4.0 ppm () and the coupled dou-
blet at 1.2 ppm (*). Residual 8-deoxyampho-
teronolide H-37 proton indicated ().
Disruption of the amphL Gene introduces the epoxide in the polyol chain of pimaricin.
Aparicio et al. disrupted pimD to produce a novel pimari-The amphotericin cluster contains two cytochrome P450
genes, amphL and amphN. The AmphN protein shows cin, de-epoxypimaricin [17]. These considerations sug-
gest that AmphL functions to introduce the C-8 hydroxyla high degree of sequence identity with the NysN, PimG,
and CanC proteins that are thought to function in forma- group of amphotericin.
The amphL gene contains two SacI sites flanking thetion of exocyclic carboxyl groups in nystatin, pimaricin,
and candicidin [15]. The AmphL protein is homologous 1053 base pair region between nucleotides 56903 and
57956 of the amphotericin cluster. This internal SacIto the NysL P450, which is thought to introduce the C-10
hydroxyl group of nystatin [16], and to PimD, which fragment of amphL was cloned between the SacI sites
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Figure 5. Proposed Routes for Production of
epi-Amphoteronolides by the Amphotericin PKS
of KC515. Recombinant phage were identified by PCR the culture. The yields were greatly reduced (2–5 mg/L)
compared to amphotericin production by S. nodosuswith oligonucleotide primers specific for the insert.
ATCC14899 [7] or 8-deoxyamphoteronolide productionSince the amphL gene appears to be located at the end
by the amphDIII mutant. The mycelium was extractedof a transcription unit, insert-directed integration of this
with methanol to give multigram quantities of extract,phage into the chromosome was not expected to have
from which partially purified polyenes were obtained bypolar effects on transcription of any other genes. A sin-
selective precipitation and column chromatography forgle crossover event would be sufficient to bring about
analysis by electrospray mass spectrometry. Analysisgene disruption. The recombinant phage was plated on
in negative ion mode gave compounds with masses ofS. nodosus, and lysogens were selected by overlaying
906.2 and 920.2 (Figure 7; all compounds show anplates with soft agar containing thiostrepton. A typical
M:M  1:M  2 ratio of ca. 6:3:1 due to isotopic naturallysogen was isolated and genomic DNA was analyzed
abundance). The M  H of 906.2 is in good agreementfor the presence of prophage DNA by Southern hybrid-
with that expected for 8-deoxyamphotericin B (1c) (M,ization and by PCR. Analysis of hybridizing restriction
907.5). The peak with a mass of 920.2 suggests thefragments indicated that gene disruption had occurred
presence of a homolog with an additional methyl group.as anticipated. A typical experiment is shown in Figure
Analysis in positive ion mode yielded masses of 930.36. Homologous recombination between the phage and
and 932.3, 944.3 and 946.3, consistent with the masseschromosomal sequences resulted in loss of the 4.8 kb
of sodium ion (M  23) adducts of 8-deoxyamphoteri-XhoI fragment that contains amphL and appearance of
cins A and B and homologs. NMR analysis of these3.4 and 43 kb junction fragments.
samples revealed resonances indicating at least two
polyenes present in large quantities of glycerides and
Analysis of Polyenes Made by the amphL Mutant an unidentified aromatic metabolite. Adequate purifica-
The amphL mutant produced heptaene and tetraenes tion of these compounds was hampered by their low
abundance in mycelia and their relative resistance tothat were found predominantly in the mycelial fraction of
Biosynthesis of Amphotericin Analogs
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Figure 6. Targeted Disruption of the amphL Gene
(A) Schematic diagram showing integration of the KC515 amphL phage into the chromosomal amphL gene. This results in loss of the 4.3 kb
XhoI fragment containing the amphL gene and formation of 3.4 and 43 kb fragments containing the 5 and 3 regions.
(B) An amphL gene probe was used to analyze the XhoI digests of genomic DNA from an amphL mutant (lane 1) and S. nodosus ATCC14899
(lane 2) by Southern hybridization.
extraction with alcoholic solvents. The deoxyamphoteri- Discussion
cins that were extracted were contaminated with over-
Manipulation of biosynthetic genes is yielding novelwhelming amounts of membrane lipids and other non-
polyene macrolides. Aparicio and coworkers have pro-polyenic material. Despite considerable effort, it has not
duced deepoxypimaricin [17] and Zotchev et al. [18]so far been possible to obtain material pure enough
have produced a hexaene derivative of nystatin as wellfor structural characterization by NMR. Therefore, the
as trace levels of a heptaene analog. This study de-designation of these compounds as 8-deoxyamphoteri-
scribes the first amphotericin analogs that have beencins rather than 16-descarboxyl-16-formylamphoteri-
generated by engineered biosynthesis and provides thecins is based on the homology between AmphL and
first insights into the order in which the late stages ofPimD (vide supra). The presence of methyl homologs of
amphotericin biosynthesis occur.these deoxyamphotericins may be due to the use of
The amphDIII mutant produced 8-deoxyamphotero-propionate as a starter unit; however, as the correspond-
nolides as major products, indicating that C-8 hydroxyl-ing homologs were not detected in the amphDIII mutant,
ation is impaired in the absence of glycosylation. Thean alternative explanation is that the 8-deoxyamphoteri-
failure of the AmphL P450 to hydroxylate the 8-deoxy-cins undergo O-methylation on the sugar residue, possi-
amphoteronolides may result from their reduced solubil-bly as a detoxification procedure. Methyl homologs of
ity or from strict molecular recognition of glycosylatedamphotericins A and B were not reported in cultures of
polyene substrates.
wild-type S. nodosus.
The C-16 carboxyl group was present in all the poly-
The 8-deoxyamphotericins retained antifungal activity enes isolated from the amphDIII mutant, with no evi-
in agar diffusion tests. The inhibition zone diameters dence for the formation of 16-descarboxyl-16-methyl-
were comparable to those of amphotericin B at equiva- amphoteronolides. This indicates that oxidation of the
lent total heptaene concentrations (data not shown). A C-16 methyl branch occurs efficiently in the absence of
partially purified fraction containing 8-deoxyamphoteri- the other two modifications. Thus, it seems likely that
cin B and its methyl homolog was tested against liquid 8-deoxyamphoteronolides are normal biosynthetic in-
cultures of S. cerevisiae. With this material, a total hep- termediates that are substrates for glycosylation. Taken
taene concentration of 1.25 g per ml was sufficient to together, these results indicate that the late stages of
inhibit growth of the yeast cells. The minimum inhibitory amphotericin biosynthesis can occur in the following
concentration for purified amphotericin B was estimated order: exocyclic carboxyl group formation, glycosylation
as 0.3125g per ml. These results indicate that 8-deoxy- with mycosamine, and finally C-8 hydroxylation.
amphotericins have a slightly lower activity than ampho- It is important to mention preliminary data that sug-
gests that this sequence of events may not be obligatorytericin B.
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Figure 7. Analysis of Polyenes Produced by the amphL Mutant by Mass Spectrometry
Analysis by ESMS in positive ion mode (A) and negative ion mode (B) showing the presence of 8-deoxyamphotericins B 1c and 1d. As
explained in the text, each of these compounds is represented by three peaks due to isotopic natural abundance. The third of the peaks
corresponding to 1c overlap with the first of the 1d peaks.
in all circumstances. We have recently disrupted the The amphL mutant produced 8-deoxyamphotericins
amphN gene after numerous unsuccessful attempts although the yields were significantly lower than the
(M.C. and P.C., unpublished data). Although purification yields of 8-deoxyamphoteronolides from the amphDIII
and chemical analyses have not yet been carried out, mutant. This may reflect regulatory phenomena or feed-
the amphN mutant produces low yields of heptaenes back mechanisms that are not yet understood. The
and tetraenes that retain antifungal activity. This raises 8-deoxyamphotericins were less soluble than ampho-
the possibility that glycosylation can occur in the ab- tericin B. However, they retained activity and could be
sence of exocyclic carboxyl group formation. Gene dis- tested as antifungal drugs. Polyenes are also active
ruption studies may not be sufficient for determining against Leishmania parasites, enveloped viruses, prion
whether these two steps occur in a preferred order. On proteins [6], and hepatocellular tumors [19]. These addi-
the other hand, this approach promises to yield several tional biological activities appear to result from interac-
amphotericin analogs rather than the few that could be tions of the polyene with sterol-rich membranes. Some
generated from a single linear pathway. of the amphotericin analogs could be useful for some
The 8-deoxyamphoteronolides had reduced water or all of these potential medical applications.
solubility and diminished antifungal activity. However,
the amphDIII mutant could be useful in glycosylation
Significanceengineering experiments aimed at altering the sugar res-
idue of amphotericin B. A wide range of aminodeoxy-
These results show that formation of the exocyclicsugars are derived from dTDP-glucose, and several
carboxyl group of amphotericin B can occur prior togroups are constructing gene cassettes for their in vivo
glycosylation with mycosamine. The second hydroxyl-synthesis in streptomycetes. Similar cassettes can be
ation, at C-8, appears to be inefficient in the absenceintroduced into S. nodosus. In addition, the amphDI
of prior glycosylation. One possible order of the mac-gene could be subjected to error-prone PCR or DNA
rolactone tailoring steps is exocyclic carboxyl groupshuffling to develop glycosyltransferases that can rec-
formation, mycosaminylation, and C-8 hydroxylation.ognize the polyene aglycone and other dTDP-glucose-
The amphDIII mutant produced 8-deoxyamphotero-derived amino sugars. Successfully redesigned gly-
nolides that had little antifungal activity. However, thiscosyltransferases could be detected by screening for
mutant strain can now be used as a host in engineeringrestored antifungal activity.
experiments to glycoslate the amphoteronolide mac-The detection of epimeric 8-deoxyamphoteronolides
rolactone with a wide range of (amino)deoxysugars,is interesting and suggests that the amphotericin system
any of which may significantly improve the therapeuticmay be useful for determining how PKS modules deter-
mine alkyl stereochemistry in nascent chains. properties over those of amphotericin B.
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Chemical MethodsDisruption of the amphL gene gave novel deoxyam-
UV spectrophotometry was performed using a Hewlett Packardphotericins that retained good antifungal activity in
8452A diode array spectrophotometer with 1 cm path length. Elec-preliminary tests. These are the first amphotericin
trospray mass spectrometry was performed on a Micromass Quattro
analogs that have been produced by engineered bio- LC. Nuclear magnetic resonance (NMR) spectroscopy was per-
synthesis. Further work should reveal whether these formed on a Bruker DRX 400 spectrometer. HPLC was performed
on a Shimadzu LC-4A with a UV detector.compounds or their derivatives have any clinical sig-
For preparative scale production and purification of polyenes, anificance as antifungal antibiotics or as antiviral, anti-
glycerol deep (1 mL) was added to GYE media (100 mL; 10 g/L yeastparasitic, or antiprion agents.
extract; 10 g/L glucose [pH 7]) and shaken in an orbital incubator
shaker (New Brunswick Series 25) at 28C for 48 hr at 160 rpm.
Experimental Procedures Portions (10 mL) of the resulting growth were each transferred to
eight 500 ml production media (fructose, 20 g/L; dextrin, 60 g/L;
Genetic Procedures soybean flour, 30 g/L; CaCO3, 10 g/L) and shaken at 28C for 72 hr
A Perkin Elmer GeneAmp 2400 thermocycler was used to carry out at 160 rpm. The growth was centrifuged (Sorvall RC-5B) and the
PCRs with Taq or Vent DNA polymerases, as described [20]. The finely divided mycelial fraction added to methanol (4 L) with occa-
oligonucleotide primers were synthesized by GenoSys, Cambridge, sional shaking for 48 hr. Yields varied from 50 mg/L to 500 mg/L of
UK. The oligonucleotides used to amplify the amphDIII region were tetraenes by UV assay with smaller amounts of heptaenes. The
5 CCGAGGATCCGCACCAGATGCAAAACGAC 3 and 5 TAAACTG supernatant was collected and reduced in volume in vacuo to ca.
CAGGACAGCACGCTGCCGGTGTTG 3. The oligonucleotides used 200 ml (largely aqueous). Centrifugation yielded a yellow precipitate
to detect the amphL phage were 5 GCGGGGATCCTAGCTGAAG that was shaken in methanol (80 mL) and the solid removed by
CAGCTGCTGCAC 3 and 5 CAGGTCGACATGGGTGGCAAC 3. centrifugation to yield a clear yellow solution whose polyene content
Methods for DNA manipulation were as described by [20]. Esche- was mainly tetraene (90%) but still contained gram quantities of
richia coli strain XL1-Blue MR was used as a host for propagation nonpolyene material (membrane components) and an unknown yel-
of plasmids. Plasmid DNA was isolated using the alkaline-SDS pro- low metabolite. Addition of excess ethereal diazomethane resulted
cedure. Restriction enzyme digestions and ligations were carried in ca. 50% of the polyene material present now having an Rf of
out using standard procedures. Competent E. coli cells for transfor- 0.45 to 0.5 with the yellow impurity at Rf 0.7 and some polyene
mation were prepared by the calcium chloride method. material remaining on the baseline (CH2Cl2:MeOH, 9:1). Purification
Methods for preparation of streptomycete spores and protoplasts by flash chromatography (CH2Cl2:MeOH, 9:1) gave a pure mixture
were those described by Hopwood et al. [21]. Streptomyces lividans of tetraenes, which were further purified by normal phase HPLC
66 (John Innes strain 1326) was used for propagation of phage (MeOH:EtOAc, 1:19), to yield 8-deoxyamphoteronolide A, an epimer,
KC515 [22]. Phage KC515 DNA was isolated using the small-scale and a third peak containing a mixture of compounds whose RMM
method [21]. DNA fragments ligated to KC515 DNA were introduced corresponded to 8-deoxy- and amphoteronolide A. Similar proce-
into S. lividans 66 protoplasts by transfection [21]. Recombinant dures were used for the growth of the amphL mutant, with extraction
phage were identified by PCR with primers specific for the cloned of the mycelia using methanol or butanol followed by selective pre-
inserts. cipitation and column chromatography.
S. nodosus ATCC 14899 was used as the parent strain for gene
disruptions. To obtain lysogens, recombinant phage were plated
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